Lv4
660 积分 2024-07-22 加入
AJCC Cancer Staging Manual
10小时前
已完结
Safety and efficacy of single-agent rovalpituzumab tesirine (SC16LD6.5), a delta-like protein 3 (DLL3)-targeted antibody-drug conjugate (ADC) in recurrent or refractory small cell lung cancer (SCLC)
2天前
已关闭
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study
2天前
已完结
Candidate Biomarker of Response to Immunotherapy In Small Cell Lung Cancer
2天前
已完结
Lung Effects of Household Air Pollution
2天前
已完结
Hemorrhagic Fever-Causing Arenaviruses: Lethal Pathogens and Potent Immune Suppressors
2天前
已完结
The global burden of lung cancer: current status and future trends
2天前
已完结
SEZ6 expression and lineage plasticity in small cell lung cancer and transformed non-small cell lung cancer
14天前
已完结
Expression of thyroid transcription factor‐1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites
17天前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
22天前
已完结
皖公网安备34019202002308
